New, more maneuverable unit joins competitors in better designed, mobile x-ray.
Carestream now has U.S. Food and Drug Administration (FDA) clearance for its DRX-Revolution Mobile X-Ray System.
Carestream put the mobile x-ray front and center at RSNA 2011, but now can take orders in the US.
The unit touts a wireless detector that can be used in other Carestream unites in a hospital to improve efficiency.
It also hosts software meant to help a radiographer quickly and accurately align the top tube with a grid for better image quality.
The top column is collapsible and a dual-drive systems enables the unit to make tight turns without strain on staff. The DRX-Revolution also offers a long tube head reach, so radiographers can conduct X-ray exams in crowded spots.
It will compete with other entries in the mobile x-ray market, such as Siemens Mobilett Mira Mobile Digital X-Ray System.
Computed Tomography Study Assesses Model for Predicting Recurrence of Non-Small Cell Lung Cancer
January 31st 2025A predictive model for non-small cell lung cancer (NSCLC) recurrence, based on clinical parameters and CT findings, demonstrated an 85.2 percent AUC and 83.3 percent sensitivity rate, according to external validation testing in a new study.